These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23537507)

  • 41. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
    Le Panse R; Berrih-Aknin S
    Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis.
    Yeo HL; Lim JY; Fukami Y; Yuki N; Lee CW
    Dev Biol; 2015 Dec; 408(2):244-51. PubMed ID: 25746216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC; McConville J; Newsom-Davis J
    Neurology; 2005 Jan; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract]   [Full Text] [Related]  

  • 46. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological and experimental studies in different forms of myasthenia gravis.
    Vincent A; Huda S; Cao M; Cetin H; Koneczny I; Rodriguez Cruz PM; Jacobson L; Viegas S; Jacob S; Woodhall M; Nagaishi A; Maniaol A; Damato V; Leite MI; Cossins J; Webster R; Palace J; Beeson D
    Ann N Y Acad Sci; 2018 Feb; 1413(1):143-153. PubMed ID: 29377162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.
    Romi F; Skeie GO; Vedeler C; Aarli JA; Zorzato F; Gilhus NE
    J Neuroimmunol; 2000 Nov; 111(1-2):169-76. PubMed ID: 11063835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
    J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is "seronegative" MG explained by autoantibodies to MuSK?
    Lindstrom J
    Neurology; 2004 Jun; 62(11):1920-1. PubMed ID: 15184587
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-agrin autoantibodies in myasthenia gravis.
    Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
    Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antititin antibody in early- and late-onset myasthenia gravis.
    Szczudlik P; Szyluk B; Lipowska M; Ryniewicz B; Kubiszewska J; Dutkiewicz M; Gilhus NE; Kostera-Pruszczyk A
    Acta Neurol Scand; 2014 Oct; 130(4):229-33. PubMed ID: 24947881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic utility of cortactin antibodies in myasthenia gravis.
    Illa I; Cortés-Vicente E; Martínez MÁ; Gallardo E
    Ann N Y Acad Sci; 2018 Jan; 1412(1):90-94. PubMed ID: 29068555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
    Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
    Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
    Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
    PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
    Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
    Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.